Amphiregulin as a biomarker of bronchopulmonary disease severity in children and adolescents with cystic fibrosis. - Amsterdam 2025

Cystic fibrosis in motion: modulators, monitoring and the whole-body impact

Chair(s): Tamara Blake, Yasemin Gökdemir

Session type: Poster session

Amphiregulin as a biomarker of bronchopulmonary disease severity in children and adolescents with cystic fibrosis.

Irena Wojsyk-Banaszak

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Real-life effect of lumacaftor-ivacaftor or tezacaftor-ivacaftor in children with Phe508del CFTR mutation

Nele Aerssens

Poster

Abstract

Impact of Kaftrio on body composition and bone health in children with cystic fibrosis

Amandine Holden

Poster

Abstract

Late Breaking Abstract - Beyond the era of modulatory therapy: Inequalities in access and their psychological impact on children with cystic fibrosis

Berrak Oztosun

Poster

Abstract

The long-term impact of targeted nutritional interventions on BMI percentiles in children with cystic fibrosis.

Seyda Karabulut

Poster

Abstract

Lung function improvement with triple modulator therapy in patients with cystic fibrosis in North Macedonia: A one-year experience

Elena Krsteska

Poster

Abstract

Factors associated with long-term lung function outcomes following elexacaftor/tezacaftor/ivacaftor treatment

Oded Breuer

Poster

Abstract

Impact of modulator therapy on microbiological trends over 9 months in North Macedonia

Elena Krsteska

Poster

Abstract

Sweat test results in patients on CFTR-modulators in Bulgaria

Ivaylo Nikolov

Poster

Abstract

Delta F508 as associated factor to impared osteoblastal acitvity in patients with cystic fibrosis

Filip Doksimovski

Poster

Abstract

Vitamin A and Th17/Treg homeostasis in children with cystic fibrosis

Tugba Sismanlar Eyuboglu

Poster

Abstract

Assessment of Bone Health in adults with Cystic Fibrosis in the Republic of North Macedonia

Tatjana Jakovska-maretti

Poster

Abstract

Clinical parameters in adult patients with cystic fibrosis on ELX/TEZ/IVA in North Macedonia

Tatjana Jakovska-maretti

Poster

Abstract

Lung function tracking and its determinants in cystic fibrosis from infancy to preschool age.

Radim Bláha

Poster

Abstract

Risk of exposure for the caregivers during aminoglycoside nebulization: an observational study

Christophe Thibon

Poster

Abstract

Lung clearance index (LCI) and lung volume (FRC) sitting vs supine in health and CF (cystic fibrosis) in relation to inert gas diffusivity

Fatma M. Al Jassim

Poster

Abstract

Amphiregulin as a biomarker of bronchopulmonary disease severity in children and adolescents with cystic fibrosis.

Irena Wojsyk-banaszak

Poster

Abstract

The hidden impact of Kaftrio: declining lean mass and aerobic capacity in children with cystic fibrosis

Amandine Holden

Poster

Abstract

Late Breaking Abstract - The short-term effects of ELX/TEZ/IVA treatment on glucose and bone metabolism in children

Cigdem Korkmaz

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}